Pharma R&D is transitioning toward an AI/data driven model of drug discovery, and great progress has been made in the last 20 years. To fully exploit the potential of this technology we must think holistically about how it is integrated into R&D. Fit-for-purpose data is essential, as are models that have causality at their heart, […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!